| ■ Breast Implants May Be Linked to Rare Cancer: FDA | 2011.01.27 |
| There may be a link between saline and silicone breast implants and a rare type of cancer called anaplastic large cell lymphoma (ALCL), the U.S. Food and Drug Administration said Wednesday. A review of scientific literature published between January 1997 and May 2010 suggests that women with these breast implants may have a very small but significant risk of ALCL in the scar capsule next to the implant. The review identified 34 unique cases of ALCL in women with either saline and silicone breast implants. The agency is asking health-care professionals to report any confirmed cases of ALCL in patients with breast implants. To ensure that women clearly understand the possible risk, the FDA will work with breast implant manufacturers to update their product labeling for patients and health-care professionals. |